Regional Sales Director, Midatlantic
$184k/y-$245k/y
Invivyd2 days ago
Highlight
OnsiteFull-timeDirector
Summary
Invivyd is seeking a Regional Sales Director, Midatlantic to lead a high-performing team of Strategic Account Managers and Virology Care Specialists in Philadelphia, PA. The role focuses on developing and executing regional business plans to drive growth in the infectious disease care market.
About the Role
As a Regional Sales Director, you will manage and motivate your team to achieve ambitious goals while building strong partnerships with healthcare providers. Your responsibilities include promoting Invivyd products, creating a coaching culture, driving sales strategies, engaging with key accounts, and ensuring compliance with industry regulations.
About You
Required:
- Bachelor’s degree (BS/BA) from an accredited college/university; Master’s degree preferred.
- Minimum of 10 years in the biopharma industry.
- 5+ years of experience managing high performing teams in the life science field.
- Diverse experience and exposure to reimbursement, buy-and-bill, specialty pharmacies, IDNs, and federal channels.
- Ability to be in the field 4 full days a week; ability to travel by car and airplane as required.
- Strong understanding and experience with laws, regulations, and industry codes governing interactions with healthcare professionals.
- Proven record of accomplishment in leading a pharmaceutical sales team.
- Strong understanding of the healthcare landscape and payer dynamics.
- Strong leadership, coaching, and recruiting skills.
- Strong presentation and communication skills.
- Ability to adapt to evolving market conditions.
- Ability to drive continuous improvement.
- Inspires an atmosphere of engagement and ethical conduct.
Benefits
- Competitive base salary with eligibility for annual short-term and long-term incentives.
- Comprehensive benefits package including health, dental, and vision coverage.
Invivyd
Invivyd, Inc. (Nasdaq: IVVD) creates medicines that are more potent and resistant to virus evolution than the human immune system. We deploy a proprietary integrated technology platform unique in the industry to assess, monitor, drug and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more. #covid19 #immunocompromised
Philadelphia, PA